New Cancer Test Can Identify the Early Signs of Mesothelioma
Mesothelioma is a rare but fatal disease that develops as a direct consequence of asbestos exposure. When a person inhales or consumes asbestos fibers, the particles damage and infect the tissues, or mesothelium, that line the lungs, heart, stomach and other organs. Although there is no cure for the disease, scientists around the world are inventing and testing new therapies, surgeries, and treatment options to extend a patient’s life.
Recently, Israeli researchers have developed a new cancer blood test that may be able to detect the early signs of mesothelioma. Currently, this disease is nearly impossible to diagnose in its early stages because it has few noticeable symptoms.
The early-to-mid stage symptoms of mesothelioma include:
- Trouble breathing.
- Pain and swelling in the abdominal region.
- Unexplained weight loss.
- Pain under the rib cage.
By the time patients become aware of their symptoms and decide to seek medical attention, it’s often too late for any effective treatment options to work. Researchers are hoping that the new blood cancer test can open doors for patients and improve mesothelioma survival statistics worldwide.
How Does the Cancer Blood Test Work
The immune system experiences unique metabolic changes when fighting against cancerous and pre-cancerous cells. For example, pleural mesothelioma causes a different metabolic reaction than breast cancer or leukemia.
Savicell Diagnostics, an Israeli immunobiopsy™ company, developed the cancer blood test to detect and interpret different metabolic pathways, subtypes of cells, and metabolic responses. The company’s diagnostic kit contains 16 chemical stimulants that serve as a type of liquid biopsy. These stimulants trigger a patient’s immune system and create a metabolic reaction that reveals cancerous cells.
What’s truly incredibly about this test – which is part of a new medical field called immunometablism – is that it can detect cancer in hours instead of weeks. So far, researchers have been able to successfully diagnose Stage I lung cancer with a 91% success rate. The company’s next mission is to make the test applicable to pleural mesothelioma, breast cancer, and other potentially fatal conditions, all with a 100% success rate.
Rely on Award-Winning Legal Representation
Contact the asbestos exposure attorneys at Shrader & Associates, L.L.P. if you or a loved one has been diagnosed with mesothelioma, asbestosis, or another asbestos-related disease. Our experienced and award-winning legal team can investigate the circumstances behind your condition, identify the negligent parties, and represent your interests in court to obtain a substantial settlement or verdict on your behalf.
Contact Shrader & Associates, L.L.P. at (855) 442-2427 to schedule a consultation today.